
Thymosin Alpha-1 (Tα1)
Thymosin Alpha-1 (Tα1)
Immune Repair • Antiviral Strength • Autoimmune Balancing • Inflammation Reduction


Benefits of Thymosin Alpha-1
Improved Energy & Recovery
Less fatigue
Better resilience
Faster return to baseline after stress or illness
Supports Healthy Cellular Immunity
Enhances immune surveillance
Supports anti-cancer immune activity
Improves immune efficiency in older adults
Inflammation & Autoimmune Regulation
Reduces abnormal inflammatory response
Modulates immune overactivation
Ideal for autoimmune flare management
Immune Strengthening
More robust immune response
Fewer infections
Faster recovery
Enhanced antiviral defence
Useful for Chronic or Recurrent Illness
Viral infections
Chronic fatigue
Post-viral syndromes
Immune suppression
How Thymosin Alpha-1 Works (Mechanisms of Action)
1. Activates & Strengthens T-Cells (CD4+, CD8+)
Tα1 enhances T-cell maturation and activation, resulting in a stronger, more coordinated immune response against infections and abnormal cells.
2. Boosts Natural Killer (NK) Cell Activity
NK cells are responsible for destroying infected or dysfunctional cells.
Tα1 increases:
NK-cell activity
Cytotoxicity
Immune surveillance
This strengthens antiviral and anticancer defence.
3. Regulates Inflammatory Cytokines
Tα1 reduces harmful inflammation by balancing cytokines such as:
IL-6
TNF-α
CRP
IFN-γ
This supports autoimmune and chronic inflammatory conditions.
4. Enhances Antiviral Immunity
Thymosin Alpha-1 increases interferon response, which is essential for:
Fighting viral infections
Preventing viral replication
Recovering faster from illness
5. Supports Immune Function in Chronic Illness
Tα1 improves immune tolerance, helping the body respond appropriately rather than excessively — ideal for:
Autoimmune conditions
Chronic fatigue
Long-standing infections
What Is Thymosin Alpha-1 (Tα1)?
Thymosin Alpha-1 is a biologically active peptide originally isolated from the thymus — the master gland of the immune system.
It plays a central role in:
training immune cells
activating T-cells
regulating cytokines
defending against pathogens
controlling inflammation
supporting immune resilience
Tα1 has been used globally in clinical settings for more than 30 years and is recognised for its immune-enhancing and immune-balancing properties with an outstanding safety profile.




Dosage, Injection Volume & Cycling
Concentration:
30 mg / 10 ml (3 mg/ml)
Dose:
Standard Dose:
1.5–3 mg, 2–3× per week
= 0.5–1 ml SC per dose
Immune Boosting Protocol:
3 mg twice weekly for 4–6 week
Maintenance::
1.5–3 mg once weekly
Synergy Stacks
Immune Strength Stack
Thymosin Alpha-1 + Glutathione
Detox + immune enhancement.
Anti-Inflammatory Repair
Tα1 + KPV + BPC-157
For gut, autoimmune, or chronic inflammation.
Energy & Recovery
Tα1 + NAD+ IM/SC
Improves resilience, mitochondrial function, and recovery.
All treatments include a brief consultation and are supervised by qualified clinicians.
Who Is Thymosin Alpha-1 Ideal For?
People With Low Immunity
Frequent colds
Slow recovery
Chronic infections
Chronic Inflammation / Autoimmune Clients
Hashimoto’s
Psoriasis
IBD
Rheumatoid conditions
Inflammation-driven fatigue
Post-Viral Cases
Long COVID
Post-viral fatigue
Recurring viral flare-ups
Older Adults
Age-related immune decline
Low T-cell activity
General Wellness & Prevention
Improving resilience
Strengthening immune defences
Supporting high-stress individuals
Cycle:
4–12 weeks depending on immune status
Repeat during seasonal illness or high-stress periods.
Injection Sites:
Subcutaneous (abdomen or thigh)
Post-Illness Regeneration
Tα1 + CJC-1295 + Epithalon
Sleep, recovery, immune modulation.
Safety & Side Effects
Thymosin Alpha-1 is one of the safest immune peptides.
Possible mild effects:
Slight fatigue
Temporary energy dip (detox response)
Mild injection-site redness
Rare headache
Mild flu-like symptoms in first 24 hours (immune activation)
No sedation, no hormonal interference, no immune suppression.
Thymosin Alpha-1 (Tα1) — Scientific Research & Clinical Studies
Comprehensive review of Thymosin α1 – Summarises mechanisms (T-cell activation, NK-cell effects, cytokine modulation) and clinical applications in viral infections, sepsis and cancer. PMC
https://pmc.ncbi.nlm.nih.gov/articles/PMC7747025/
Immune landscape modulation in COVID-19 – Study showing Tα1 modulates immune responses, improves immune profiles and has potential as an adjunct in COVID-19. ScienceDirect
https://www.sciencedirect.com/science/article/pii/S1567576923013085
Tα1 as adjunct in unresectable hepatocellular carcinoma – Combination of Thymosin α1 with lenvatinib and sintilimab improved outcomes without added severe toxicity. Nature
https://www.nature.com/articles/s41598-025-97160-7
ClinicalTrials.gov summary (COVID-19 and other infections) – Details broader clinical use of “thymalfasin” (synthetic Tα1) in sepsis, hepatitis B and viral infections. ClinicalTrials.gov
https://clinicaltrials.gov/study/NCT04487444
Clinical Disclaimer
This page summarises clinical immunology research, peer-reviewed studies, and thymic peptide science. Thymosin Alpha-1 at The NAD Clinic is administered under research-based wellness protocols and is not intended to diagnose, treat, or cure disease.



